This record was last updated February 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-229 and the administration of AD-2291 in healthy adults.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-27.